NSGNurse Study Group

NCLEX-style practice question

A nurse is caring for a client with Alzheimer disease who is prescribed donepezil. The client's family asks whether this medication will stop the progression of the disease. Which response by the nurse is most accurate?

  1. The medication stops the buildup of beta-amyloid plaques in the brain.
  2. The medication will slow the disease course over several years.
  3. The medication treats cognitive symptoms but does not change the underlying disease process.
  4. The medication reverses the brain cell loss that has already occurred.
Show answer and rationale

Correct answer: C. The medication treats cognitive symptoms but does not change the underlying disease process.

Donepezil is a cholinesterase inhibitor that affects neurotransmitter levels to manage cognitive symptoms but does not alter the underlying brain changes or slow disease progression. The beta-amyloid-targeting drugs such as lecanemab are the ones associated with slowing decline, so the family's expectation of stopping progression is incorrect.

Adapted from Nursing Fundamentals 2e.

Category: Pharmacological and Parenteral Therapies / Pharmacological Therapies

Practice every question freeFree account: the full question bank, NCLEX-RN and PN practice exams, flashcards, an AI study tutor and a study group forum.
Create a free account

More Pharmacological and Parenteral Therapies / Pharmacological Therapies questions

See all 440 →

Practice questions are study aids written with AI from openly licensed nursing textbooks and can contain mistakes. They are not NCLEX questions and are not endorsed by NCSBN.